Home Healthcare IT China Cell and Gene Therapy Manufacturing QC Market Growth Analysis 2033

China Cell and Gene Therapy Manufacturing QC Market Size & Outlook, 2025-2033

China Cell and Gene Therapy Manufacturing QC Market Size, Share & Trends Analysis Report By Therapy Type (Cell Therapy, CAR-T, CAR-NK, B-Cell, Others, Gene Therapy, Viral, Non-viral), By Scale (Pre-commercial/ R&D Manufacturing, Commercial Scale Manufacturing), By Mode (Contract Manufacturing, In-house Manufacturing), By Workflow (Cell Processing, Cell Banking, Fill & Finish Operations, Raw Material Testing, Vector Production, Other Workflows), By Process (Upstream Processes, Downstream Processes), By End-User (Pharmaceutical Companies, Biopharmaceutical / Biotechnological Companies, Contract Manufacturing Organizations), By Technology Type (Fluorescence-Activated Cell Sorting (FACS), Enzyme-Linked Immunosorbent Assay (ELISA), Chromatography, Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Others) and Forecasts, 2025-2033

Report Code: SRHI56473DR
Last Updated : Jul, 2025
Pages : 80
Author : Debashree Bora
Format : PDF, Excel

Market Segmentation

  1. China Cell and Gene Therapy Manufacturing QC Market, By Therapy Type (2021-2033)
    1. Cell Therapy
      1. CAR-T
        1. Autologous CAR-T
        2. Allogeneic CAR-T
      2. CAR-NK
      3. B-Cell
      4. Others
    2. Gene Therapy
      1. Viral
        1. AAV
        2. Lentiviral vectors
        3. Other
      2. Non-Viral
  2. China Cell and Gene Therapy Manufacturing QC Market, By Scale (2021-2033)
    1. Pre-commercial/ R&D Manufacturing
    2. Commercial Scale Manufacturing
  3. China Cell and Gene Therapy Manufacturing QC Market, By Mode (2021-2033)
    1. Contract Manufacturing
    2. In-house Manufacturing
  4. China Cell and Gene Therapy Manufacturing QC Market, By Workflow (2021-2033)
    1. Cell Processing
    2. Cell Banking
    3. Fill & Finish Operations
    4. Raw Material Testing
    5. Vector Production
    6. Other Workflows
  5. China Cell and Gene Therapy Manufacturing QC Market, By Process (2021-2033)
    1. Upstream Processes
    2. Downstream Processes
  6. China Cell and Gene Therapy Manufacturing QC Market, By End-User (2021-2033)
    1. Pharmaceutical Companies
      1. Small Size
      2. Medium Size
      3. Large Size
    2. Biopharmaceutical / Biotechnological Companies
      1. Small Size
      2. Medium Size
      3. Large Size
    3. Contract Manufacturing Organizations
      1. Small Size
      2. Medium Size
      3. Large Size
  7. China Cell and Gene Therapy Manufacturing QC Market, By Technology Type (2021-2033)
    1. Fluorescence-Activated Cell Sorting (FACS)
    2. Enzyme-Linked Immunosorbent Assay (ELISA)
    3. Chromatography
    4. Next-Generation Sequencing (NGS)
    5. Polymerase Chain Reaction (PCR)
    6. Others

Available for purchase with detailed segment data, forecasts, and regional insights.

Get This Report

Download Free Sample

Note: Please ensure you provide an active email address as we will be sending sample details via email.
The button will be active once the above form is filled

We are featured on :

Address:
Office 515 A, Amanora Chambers,
Amanora Park Town, Hadapsar,
Pune 411028, Maharashtra, India.
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
DMCA.com Protection Status
Secure Payments:
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.